> ## Content Index
> Fetch the complete content index at: https://www.techloy.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# China's AI drug discovery firm Insilico raises $60 million in Series D round
- URL: https://www.techloy.com/chinas-ai-drug-discovery-firm-raises-60-million-in-series-d/
- Published: 2022-06-06T16:54:40.000Z
- Updated: 2022-12-08T01:09:41.000Z
- Author: Oluwajuwonlo Afolabi
- Tags: / Artificial Intelligence, Tech in China, Health Tech

[Insilico,](https://insilico.com/) a China-based AI-focused drug discovery firm has raised $60 million in its Series D funding round.

- The funds will be used to support its Phase I Studies (Clinical trial and safety testing), develop its drug discovery platform, enter international markets, and build a robotic drug discovery lab and a robotic biological data factory.
- The firm provides drug discovery services since it launched and is now offering therapeutics in fibrosis, immunology, oncology, and the central nervous system, with eight candidates nominated so far.
- It last raised $255 million in its Series C a year ago.
- Warburg Pincus, B Capital, Qiming Venture Partners, BOLD Capital Partners, and Pavilion Capital participated in the new funding round.